FIELD: biotechnology; medicine.
SUBSTANCE: disclosed is a method of treating intestinal dysbiosis in the postoperative period in patients with a craniocerebral injury. Method involves administering a metabiotic preparation containing, in the specified ratio of components, wt.%: complex of lysates of bacterial strains Bifidobacterium bifidum, Bifidobacterium adolescentis, Bifidobacterium animalis, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium longum infantis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus delbrueckii subsp.bulgaricus, Lactobacillus salivarius, Lactobacillus rhamnosus, Lactobacillus helveticus, Streptococcus thermophilus, maltodextrin, a concentrate for a non-alcoholic beverage Kambiochai, gum arabic and lactic food acid. Metabiotic preparation is administered in dose of 0.2 gram 2 times day for 21 days.
EFFECT: invention provides effective treatment of intestinal dysbiosis in postoperative period in patients with craniocerebral injury.
1 cl, 2 dwg, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ENTERAL DIABETIC MIXTURE CONTAINING METABIOTIC COMPLEX AND β-GLUCANS, FOR TREATMENT OF NUTRITIONAL DEFICIENCY IN CRITICALLY ILL PATIENTS | 2024 |
|
RU2832794C1 |
| METHOD OF TREATING NUTRITIONAL DEFICIENCY IN PATIENTS WITH SEPSIS WITH ENTERAL MIXTURE CONTAINING METABIOTIC COMPLEX AND β-GLUCANS | 2024 |
|
RU2828960C1 |
| METHOD OF TREATING NUTRITIONAL DEFICIENCY IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME OF MILD, MODERATE AND SEVERE ENTERAL MIXTURE CONTAINING METABIOTIC COMPLEX AND β-GLUCANS | 2024 |
|
RU2834562C1 |
| AGENT FOR REDUCTION OF INTESTINAL MICROBIOCENOSIS IN CASE OF DYSBIOSIS | 2015 |
|
RU2593584C1 |
| METHOD OF PRODUCING FODDER COMPOSITION WITH FUNCTIONAL PROPERTIES FOR POULTRY FARMING | 2023 |
|
RU2819889C1 |
| LIQUID SYMBIOTIC AND METHOD FOR OBTAINING IT | 2022 |
|
RU2805957C1 |
| METHOD FOR MANUFACTURING ENCAPSULATED FORM OF A PROBIOTIC FOOD SUPPLEMENT | 2021 |
|
RU2795965C1 |
| METHOD FOR PRODUCTION OF DRY FERMENTED MILK PRODUCT | 2022 |
|
RU2801106C1 |
| COMPOSITIONS CONTAINING PROBIOTIC AND PREBIOTIC INGREDIENTS AND INORGANIC SALTS WITH LACTOFERRIN | 2010 |
|
RU2536939C2 |
| METHOD OF PREVENTING ATOPIC DERMATITIS IN INFANTS BY MODULATING MICROBIAL MECHANISM OF HISTAMINE FORMATION | 2017 |
|
RU2665173C1 |
